ELS exhibits significant fundamental weakness, highlighted by a critical Piotroski F-Score of 2/9, indicating deteriorating financial health. The stock is trading at a massive premium compared to its Graham Number ($20.22) and Intrinsic Value ($14.0), with a current price of $63.29. Most concerning is the unsustainable dividend payout ratio of 104.38%, suggesting the company is returning more capital to shareholders than it is earning. While analyst sentiment remains bullish, the deterministic data reveals severe liquidity risks and stagnant growth.